Bivalirudin Injection, Solution
Product Images NDC 42023-622

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bivalirudin (NDC 42023-622). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Par Health Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemicalstructure.jpg (Bivalirudin Injection 1)

Chemicalstructure.jpg (Bivalirudin Injection 1)
Chemical structure diagram of the active ingredient Bivalirudin, showing its amino acid sequence and peptide bonds in a linear and cyclic peptide arrangement.*
FDA Label Image

Carton Image (Bivalirudin Injection 2)

Carton Image (Bivalirudin Injection 2)
Label for Bivalirudin Injection 250 mg/50 mL (5 mg/mL) single-dose vial by Par Pharmaceutical. The label states it is for intravenous use only and ready to use with instructions not to dilute. It includes storage information advising refrigeration between 2° to 8°C and limited room temperature storage. The label displays the NDC 42023-622-01 and barcodes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.